Find a Top Internist Near Me in Mesa, AZ – Book an Appointment Instantly

Lauren Havard, MD, is a family medicine and primary care physician. She serves patients at HealthyU Clinics at our Phoenix, Arizona, clinic. 

Dr. Havard joined HealthyU Clinics in 2021. She previously worked as an outpatient family physician at two Banner Medical Group clinics in Phoenix, Arizona. She also worked at Banner Boswell Medical Center in Sun City, Arizona, mid-pandemic, as a hospitalist. 

Dr. Havard completed her residency at Abrazo Central Family Medicine Residency Clinic in Phoenix, Arizona. She attended medical school at the American University of the Caribbean School of Medicine in St. Marteen. 

During medical school, she spent her third year in Chichester, England (where she met her husband), and her fourth year in the United States.  

Dr. Havard and her husband love spending time with their dog Lily, playing co-ed soccer, hiking, working out, listening to music, watching binge-worthy shows, and most importantly spending time with friends and family.

Teodor Pitea, MD

Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.

Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.

In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.

During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.

Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.

Dr. Kaplan treats a wide variety of medical oncology, malignant hematology, and benign hematologic disease. She is especially interested in treating breast cancer and general oncology.

Dr. Kaplan enjoys cooking, reading, watching sports, traveling, and spending time with family and her 2 dogs named Penny.

"Dr. Kaplan was a major part of my father-in-love’s cancer treatment and was one of his biggest champions. Her bedside manner was incredibly personalized, kind, and intentional. He couldn’t say enough wonderful things about her. I highly recommend her!" -Leanne

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Zaher Akkad, MD, FACC, is a cardiologist at Affiliated Cardiologists of Arizona, with four locations in Phoenix, Maricopa, Goodyear, and Chandler, Arizona. Dr. Akkad holds multiple board certifications, including internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology, and echocardiography, as well as Endovascular Medicine.

Dr. Akkad was trained at Wayne State University-affiliated hospitals in Detroit, Michigan. Before joining Affiliated Cardiologists of Arizona, Dr. Akkad was an Assistant Professor of Internal Medicine and Cardiology at Wayne State University. During this time, he was the Interim Director of the Echocardiography Lab. 

He has published multiple textbook chapters in the fields of cardiomyopathy, myocarditis, and congestive heart failure.

Dr. Akkad’s clinical skills are outstanding. He is a multi-talented cardiologist, he is experienced in all aspects of non-invasive cardiology, including echocardiography, transesophageal echo, and nuclear cardiology. He is a fully-trained interventional cardiologist with superb skills in all aspects of cardiac Catheterization and stents also endovascular, carotid and peripheral interventions as well as pacemaker implantation. He is experienced in Structural Cardiac interventions including TAVR and  Watchman procedures. 

Dr. Akkad is very compassionate and has exceptional patient skills. His philosophy is to treat his patients as if they are family and provides prompt, cutting-edge, and evidence-based treatments. He is currently accepting new patients and eager to help them get healthy as soon as possible. Please check the testimonials from some of our patients below.  On behalf of Dr. Akkad and his team, we look forward to taking care of you.

Soy cardióloga que habla español.

Testimonials

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. Clarence Adoo specializes in hematology, oncology and internal medicine. He joined Arizona Center for Cancer Care in 2008. Dr. Adoo is a member of the American College of Physicians/American Society of Internal Medicine, American Association of Blood Banks, American Society of Hematology and American Society of Clinical Oncologists amongst others. 

Dr. Adoo has publications in several journals and authored many chapters in books, including Acute Myeloid Leukemia, Alternative Management Strategies in Alloimmunized Thrombocytopenic Patients, Infection in the Neutropenic Host, Management of infection in Oncology Patients and Adult Leukemia: American Cancer Society Atlas. In addition to his published work, Dr. Adoo has participated in several presentations at the Hematology Oncology Fellowship Program, National Institute of Health, Leukemia and Lymphoma Society/Cure for Lymphoma Association and Phoenix Veterans Affairs Hospital.

He has been honored as a fellow by the American College of Physicians and lauded by America’s Registry of Outstanding Professionals, among other honors.

Patient Reviews:

"He was the best. always listened to me and addressed the issue. Vary caring." -Cliff

"We are amazed at how Dr. Adoo makes us feel, very welcoming, is ready to answer any questions we have and even calls other drs if necessary. His bedside manner is the best we have had from any doctor. We would recommend him to anyone and everyone needing a Dr. with his experience." -Casimir

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. Jason Samuelian is a Board-certified Radiation Oncologist, with expertise in novel radiation techniques including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiosurgery (SRS), and Stereotactic Ablative Radiotherapy (SABR). He has a particular interest in using new and advanced treatment techniques to minimize side effects. He derives great satisfaction from spending time with his patients and developing relationships with them that last long beyond their cancer care.

Dr. Samuelian joined Arizona Center for Cancer Care in 2015. He earned his Bachelor of Science degree in Exercise Physiology from Brigham Young University, where he graduated cum laude. He earned his medical doctorate at Midwestern University in Glendale, where he was awarded the MICA Scholastic Award in 2008, and graduated with Honors in 2010. He completed an internal medicine internship at Banner Good Samaritan Medical Center, followed by residency training at the Baylor College of Medicine, where he also served as chief resident. In addition, Dr. Samuelian has completed two brachytherapy fellowships — at the MD Anderson Cancer Center and the Seattle Prostate Institute.

Dr. Samuelian is a member of the American Society of Therapeutic Radiation Oncology, American Brachytherapy Society, American College of Radiology, American College of Radiation Oncology, and the American Society of Clinical Oncology. He has been invited to serve on the ASCO Professional Development Committee. He currently serves as Chairman of the Cancer Committee at Banner Boswell Medical Center in Sun City, a program accredited by the Commission on Cancer (CoC).

Dr. Samuelian actively participates in cooperative group clinical trials. His research has been published in peer-reviewed medical journals, and he has presented at national meetings on SABR for COPD patients with early-stage lung cancer, IMRT for the treatment of rectal cancer, and prostate cancer brachytherapy, among others.

Patient Reviews:

"Dr. Samuelian has always been very honest and truthful in presenting us with our options I trust his opinion 100 present and would highly recommend him to anyone seeking his treatment." -Rick

"I have been very impressed with Dr. Jason Samuelian. He seems extremely knowledgeable. I have had several doctors that had horrible bedside manner. Dr. Samuelian has an incredible bedside manner. It was so obvious that he was really concerned with my welfare. I would also like to do a shout out to his support team. They were incredible, and kind. I can't say enough about the entire experience. I'd give him six stars if I could." -Peter

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Teodor Pitea, MD

Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.

Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.

In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.

During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.

Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.

Dr. Andrew J. Buresh specializes in medical oncology, hematology, and internal medicine. He is interested in all aspects of clinical oncology and hematology, with a particular interest in gastrointestinal, breast, lung, and prostate cancer, as well as myelodysplasia, coagulation disorders, lymphoma, and myeloma.

Dr. Buresh joined Arizona Center for Cancer Care in 2013 when Desert Springs Cancer Care Center, which he founded and partnered with the practice. He is a member of the American Society of Clinical Oncology, American Society of Hematology and Arizona State Physicians Association.

Dr. Buresh is a multi-year “Top Doc” honoree by Phoenix Magazine and was chosen for the cover of the annual ranking magazine in 2013. He was also honored by the Phoenix Business Journal as among its “40 Top Business Leaders under Age 40.”

Dr. Buresh and his wife are blessed to be the proud parents of three beautiful children. When not caring for patients, Dr. Buresh enjoys spending his time with family, exercising, reading, playing basketball, golf, guitar, and coaching youth sports. He also speaks basic medical Spanish.

Patient Reviews:

"Warm and caring in all aspects of care. He’s special in his approach and looks at the big picture. Spends a lot of time asking questions and is conservative in his approach. So glad I was referred to him and will continue to refer him to others. Don’t be afraid~ take him on your journey with you!" -Robin

"Excellent Hematologist/Oncologist!!!" -Medi

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/